OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
Konstantinos Venetis, Francesco Pepe, Carlo Pescia, et al.
Cancer Treatment Reviews (2023) Vol. 121, pp. 102642-102642
Closed Access | Times Cited: 14
Konstantinos Venetis, Francesco Pepe, Carlo Pescia, et al.
Cancer Treatment Reviews (2023) Vol. 121, pp. 102642-102642
Closed Access | Times Cited: 14
Showing 14 citing articles:
The biological and technical challenges facing utilizing circulating tumor DNA in non-metastatic breast cancer patients
Zihang Zeng, Zongbi Yi, Binghe Xu
Cancer Letters (2025) Vol. 616, pp. 217574-217574
Closed Access | Times Cited: 1
Zihang Zeng, Zongbi Yi, Binghe Xu
Cancer Letters (2025) Vol. 616, pp. 217574-217574
Closed Access | Times Cited: 1
Next-generation sequencing for PTEN testing in HR+/HER2˗ metastatic breast cancer
Nicola Fusco, Umberto Malapelle
Critical Reviews in Oncology/Hematology (2025), pp. 104626-104626
Closed Access
Nicola Fusco, Umberto Malapelle
Critical Reviews in Oncology/Hematology (2025), pp. 104626-104626
Closed Access
The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer
Liang Jin, Zijian Yang, Wei Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Liang Jin, Zijian Yang, Wei Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Liquid biopsies in cancer
Hang Yin, Manjie Zhang, Yu Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Hang Yin, Manjie Zhang, Yu Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
The role of <i>ESR1</i> gene mutation in therapy selection for HR+/HER2- metastatic breast cancer: A review
А. А. Пайчадзе, Ekaterina P. Chashnikova, S. A. Golubeva
Journal of Modern Oncology (2025) Vol. 26, Iss. 4, pp. 410-413
Open Access
А. А. Пайчадзе, Ekaterina P. Chashnikova, S. A. Golubeva
Journal of Modern Oncology (2025) Vol. 26, Iss. 4, pp. 410-413
Open Access
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors
Carolina Reduzzi, Eleonora Nicolò, Surbhi Singhal, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104483-104483
Closed Access | Times Cited: 3
Carolina Reduzzi, Eleonora Nicolò, Surbhi Singhal, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104483-104483
Closed Access | Times Cited: 3
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
Elena Guerini-Rocco, Konstantinos Venetis, Giulia Cursano, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104427-104427
Closed Access | Times Cited: 2
Elena Guerini-Rocco, Konstantinos Venetis, Giulia Cursano, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104427-104427
Closed Access | Times Cited: 2
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations
Luca Boscolo Bielo, Elena Guerini‐Rocco, Dario Trapani, et al.
ESMO Open (2024) Vol. 9, Iss. 10, pp. 103731-103731
Open Access | Times Cited: 2
Luca Boscolo Bielo, Elena Guerini‐Rocco, Dario Trapani, et al.
ESMO Open (2024) Vol. 9, Iss. 10, pp. 103731-103731
Open Access | Times Cited: 2
The “lows”: update on ER-low and HER2-low breast cancer
Nicola Fusco, G. Viale
The Breast (2024) Vol. 78, pp. 103831-103831
Open Access | Times Cited: 2
Nicola Fusco, G. Viale
The Breast (2024) Vol. 78, pp. 103831-103831
Open Access | Times Cited: 2
Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR
Stavroula Smilkou, Aliki Ntzifa, Dimitra Stergiopoulou, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100154-100154
Open Access | Times Cited: 1
Stavroula Smilkou, Aliki Ntzifa, Dimitra Stergiopoulou, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100154-100154
Open Access | Times Cited: 1
Ultrasensitive detection of circulating tumor DNA using a CRISPR/Cas9 nickase-driven 3D DNA walker based on a COF-AuNPs sensing platform
Yuxin Wei, Yang Fu, Chuanhai Li, et al.
Microchimica Acta (2024) Vol. 191, Iss. 11
Closed Access | Times Cited: 1
Yuxin Wei, Yang Fu, Chuanhai Li, et al.
Microchimica Acta (2024) Vol. 191, Iss. 11
Closed Access | Times Cited: 1
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer
Valerio Gristina, Gianluca Russo, Tancredi Didier Bazan Russo, et al.
Expert Review of Respiratory Medicine (2024), pp. 1-11
Closed Access
Valerio Gristina, Gianluca Russo, Tancredi Didier Bazan Russo, et al.
Expert Review of Respiratory Medicine (2024), pp. 1-11
Closed Access
Circulating Tumor DNA in Early and Metastatic Breast Cance—Current Role and What Is Coming Next
Christian M. Tegeler, Andreas D. Hartkopf, Maggie Banys‐Paluchowski, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3919-3919
Open Access
Christian M. Tegeler, Andreas D. Hartkopf, Maggie Banys‐Paluchowski, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3919-3919
Open Access
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention and clinical impact
Hanna Huebner, Pauline Wimberger, Elena Laakmann, et al.
Precision Clinical Medicine (2024) Vol. 8, Iss. 1
Open Access
Hanna Huebner, Pauline Wimberger, Elena Laakmann, et al.
Precision Clinical Medicine (2024) Vol. 8, Iss. 1
Open Access
